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ABSTRACT  
Four month ago, nobody knows about covid-19 but now this virus has spread to almost every country, infecting at least 3,062515 people and 
death approx 211449 people with badly impact on economies of the most countries and also broken their health-care systems. At this time 
covid-19 disease is almost spreading all over the world and society. Majorly Pharmacy services act as a pillar at this pandemic situation for the 
public health. China is the first country where covid-19 outbreak started and some current data of consumer behavior and their habits are 
showed that society take some safe and preventive measures during lockdown and social distancing time which increase growth of ecommerce 
demand is inevitable. Now a day’s e-pharmacy is being adapted because medications can be ordered in a one click and conveniently delivered to 
customer door step with some risk like misuse of drugs and self-medication especially for those drugs which comes under the schedule H and X. 
This review paper focus on the basic issues and challenges related to online pharmacy and how can it be beneficial to society  and pharma 
sectors in the pandemic situation.   
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1. INTRODUCTION:  
In the meanwhile from past decades the way to purchase 
products and services changes and basically internet take 
over the market and customer buying medications online 
frequently. Online pharmacy has not only benefits but also 
have some patient safety risks in purchase of medicines 
apart from traditional chain1. Due to covid-19 lockdown 
mostly consumers prefer to purchase medicine 
online. Governments are taking all essential steps for 
protecting lives by imposing lockdowns, testing, segregation, 
and treatment. As we all know that infection is spread all 
over the world so people restricts outdoor movement. For 
wholesale and retail trade e- commerce is continuously 
growing day by day. E-commerce companies have witnessed 
that orders as customers are in online is spike about 20-30% 
2. Globally 2986 online pharmacies were operating in the 
year 20083. In India 65 Online pharmacy startup were 
established in 2005 so we have to change the traditional 
approaches in pharmacy especially the Internet which adds 
immense value by improving accessibility of healthcare 
services even to the most remote regions of the country. At 
the pandemic time for the safety concern consumer buying 
each everything through online system and also choose 
home delivery for all essential goods and medicines. So that’s 
why companies are promoting their business through digital 
technologies and online medicine purchase is popular 
worldwide due to convenience4. In North America and 
Europe market of the e-pharmacy is approx 29.3 US$ billion 
in 2014 as a report said and has been estimated to grow at a 
CAGR of 17.7% to reach a valuation of US$ 128 billion by 
2023 (FICCI, 2016). In India e-Pharmacy is at its beginning 
stage in India with various affects, may be in future it has the 
potential to be a very large industry segment 5. 
1.1 E-Pharmacy:  
In past time hand written prescription method for 
distribution of medicine was favorable but the market of 
medicine distribution is now being replaced because the 
boom in the e-commerce so the medicine also distributed 
online by giving electronic prescription and commonly 
known as e-pharmacy and also known as, Online, Internet 
,Cyber, Tele pharmacy. It is expected that phrama sales in 
India could be affected by e-pharmacy model approx 5-15%, 
if it is held between largely accesses to the medicines for 
under-served population6. It improves convenience and 
access of consumer. It is importantly benefits those patients 
who have chronic diseases in a binuclear family and those 
patients who are not able to go out to find a pharmacy. E-
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pharmacy is a pharmacy that operates over the Internet and 
sends orders to customers through mail, shipping 
companies, or online pharmacy web portal. In 2018 the 
report shows that global e-pharmacy market was 
approximately USD 42.32 billion and it is expected to 
generate around USD 107.53 billion by 2025, at a CAGR of 
around 14.26% between 2019 and 2025 (Globe news wire 
2019)7. Many e-Pharmacy key players are Pharmeasy 
Medlife, 1MG, Netmeds Myra, CareOnGo and Pharmasafe 
operates online business. Medlife is leading with about 30% 
market share of the total e-pharmacy market in India 8, 9.  
1.2 Types of E- Pharmacies 
E pharmacies basically are three types. 
1. First one is like traditional drug stores which may be an 
independent from Internet Company and one operating 
stores and mail order pharmacies that dispense medicines 
after receiving prescription.  
2. Second one may be clicks-and mortar pharmacy, Major 
pharmacy has branch chain as actual storefront. In this 
medication provide by an examination of patient online 
without physical consultation. This online medication is 
basically depends upon the questionnaire process evaluated 
by physician 10.  
3. Ones that dispense medication without a prescription. The 
first type receives certification from private organization 
watchdogs and licenses from the states in which they 
operate. The other two types raise public safety concerns.  
Some Pharmacy models are also detailed here. The 
Inventory-based Model means goods and services sold to 
customer directly in e-Commerce. The Marketplace-based 
Model means that it provides information technology 
platform between a buyer and a seller through Digital 
network 11.  Online business model is shown on Fig 1.
  
 
Figure 1:  E-Pharmacy Model 
 
1.3 How does an E -Pharmacy model works?  
1.  A scan copy of prescription uploads on the Web or 
Mobile-based application for medicines request.  
2. A team of a registered pharmacist should be checked and 
verified each and every order.  
3. The validated prescriptions send to the pharmacy store by 
registered pharmacist where medicine can be dispensed  
4. All the consumer and pharmacy store activity is govern by 
IT Act 2000 on the web or mobile based system 12. 
1.4 Advantages 13: 
1. Money saving 
2. Saving Time  
3. Consumer convenience is increased 
4. Medicines availability is increased   
5. Easy accessibility to medicine  
6. 24/7 access possible 
7. Policy of  refund  
8. One can easily compare medicines in terms of cost 
9. Increased consumer information and information 
exchange 
10. Privacy 
11. Delivery of medicines at desired place at desired time 
possible 
12. Fast distribution 
13. Increased choice as wider variety of medicines 
available. 
14. Convenient for some patients and old age people who 
can’t leave their home. 
1.5 Disadvantages 14: 
1. Chances of drug resistance and interaction  
2. Promote self-medication 
3. Chances of drug abuse 
4. Financial privacy issues 
5. Chances of misdiagnosis 
6. Chances of drug misuse 
7. Purity and quality of drugs not assured  
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8. Electronic health records security and privacy 
concerns 
9. Risks associated with online purchasing of drugs 
10. Medical privacy is a major concern 
11. Easy availability of illegal substances 
12. Sale of drugs without prescription by some e-
pharmacies which lead to harmful consequences 
13. Online prescription without consulting a doctor 
14. Doctor’s prescription may not be honoured 
15. Doctor- Pharmacist- Patient: This trio trust evaporates 
16. Affect business of offline pharmacists 
17. Access to illiterate and poor population difficult 
18. Authentication of physicians and pharmacist online is 
unclear 
19. Labelling and packaging related issues 
20. Differentiation between legitimate and illegitimate 
websites for e-pharmacy is tough  
21. Temperature sensitive drugs transport is complicated  
1.6 Challenges 15: 
1. For governing e-pharmacies in India a tactile laws in 
need  
2. To sell of drugs to the minors 
3. Reach of technology driven model to illiterate people 
due to lack of knowledge about internet 
4. Speed of internet 
5. Prescription related issues 
6. Legality of electronic signature 
7. Identity and reliability of legal e-pharmacy 
8. Protection of consumer rights 
9. Security and confidentiality of information exchanged 
10. Security of financial transactions 
11. Regulatory control over e-pharmacies operating 
outside the jurisdiction of India 
12. Unclear laws on inter-state transfer of 
drugs/medicines. 
13. Drug importation and re-importation issue 
2. E-PHARMACY REGULATION IN INDIA  
Regulatory powers in India have been distributed between 
the central and the state governments. State governments 
mainly responsible for the manufacturing sale and 
distribution of medicines while Central Government provide 
licensing to import of medicines 16. Two main organization 
in Central and State Government for the regulatory control 
over drugs are Central Drugs Control Organization (CDCO) 
leaded by the Drugs Controller General India and Drugs 
Control Administration (DCA) leaded by the State Drugs 
Controllers. States has its own Drugs Control Administration. 
Law which control over pharmacy regulation are Drug and 
Cosmetics Act 1940, Drugs and Cosmetic Rules 1945, 
Pharmacy Act 1948,  Indian Medical Act 1956 and  Laws 
related to e-commerce are defined under the Information 
Technology Act, 2000. Except emergency cases, doctor 
cannot consult through phone said by Supreme Court. As far 
as India is concerned, there are no dedicated e-health and 
telemedicine laws in India. So basically there is no law 
control over E-pharmacy 17. We noticed that laws governing 
the E-pharmacy model as not certain applicability so that 
key player taking advantage for their business and also 
found that they are not properly follow the regulation 
guidelines. There are not clear provisions regarding sale of 
drugs from internet, it seems very difficult to control, 
monitor and track sell of drugs through e-pharmacies. 
3. E-PHARMACY DRAFT GUIDELINES: 
 Union Health Ministry drafted some rule for the proper 
regulation of the e-pharmacies on the selling of drug at 28th 
August 2018. DCGI is a sole agency that should propose the 
draft guidelines. Two regulatory bodies keep on eye the 
regulation of the e-commerce of online pharmacies business 
that is Drugs and Cosmetics Rules 1945 as well as the 
Information Technology Act 200018. For e-Pharmacies 
companies are required to take one license in any state and 
it enable the pharmacies to sell drugs all over the country. If 
in any circumstances portal failing the follow the guideline 
under the regulation there should be suspension and 
cancellation of e-pharmacies so portal should comply all the 
provision under The Drug and Cosmetic Act, 1940. The drugs 
should be dispensed under the supervision of registered 
pharmacist who must verify the details of the patient. The 
details of the drugs dispensed along with the patient details 
are to be maintained on the e-Pharmacy portal. Central 
Licensing Authority is responsible for the registration of the 
e-pharmacies for running a business with filling a form 18AA 
along with 50,000 fees and basically it is very important to 
do a registration for e-Pharmacy portal in selling, 
distributing, stocking, exhibiting, or offering for sale of 
drugs. Registration would remain valid for 3 year from 
effective issue date. Duration of the audit by an authorized 
team of the CLA is 2 year. After expiration of the registration 
person should be renew the registration in between 6 month 
of duration 19. 
Narcotic Drugs and Psychotropic drugs do not come under e-
Pharmacy sale.  
Prashant Singh Co-founder, Medlife said “The government as 
well the CDSCO is very supportive of ePharmacies. There are 
no regulatory pressures other than expectations of following 
the laws. The HC judgment too was only with regards to 
pharmacies selling online who do not carry the valid licenses 
to dispense and hence operate illegally” 20. 
4. COMPARISON OF RETAIL OVER E-PHARMACY  
There are various factors that affect both the online and 
offline pharmacy run. 
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Table: 1 Comparison of Retail and E-Pharmacy Aspect 21 
S. No. E-pharmacy Retail Pharmacy 
1 One can order medicines anywhere through internet 
so it is more convenient form.  
Patients go to store for the buying medicines so it is 
consider as less convenient form.  
2 Availability of procurement is larger so more 
inventory items  
Less inventory  
3 It saves time because of doorstep delivery  It is time consuming as compared to e-pharmacy.   
4 Range of medicines are more  Range of medicine is less  
5 It provide discount on medicines so offer lower price  They are not give such offer like online pharmacy due to 
less margin 
  
5. SOME ONLINE PHARMACY STARTUP  
Table 2: Some of the startup of online pharmacy in India 22. 
S. No  Online Startup  Location  Website  Target  
1. HealthKart 2011 India  www.healthkart.com Online store for health, sport and nutritional 
supplements  
2. 1mg 2015  India  www.1mg.com Online pharmacy marketplace with doctor 
listing and tele consultation services  
3. Medlife  2014 India  www.medlife.com Medlife offers an app for purchasing 
medicines. 
4. PharmEasy  2015 India www.pharmeasy.in Mobile-first hyperlocal platform for medicine 
ordering and diagnostic tests 
5. NetMeds 2015 India  www.netmeds.com It offers an online platform selling 
prescription, over-the-counter (OTC) drugs 
and healthcare and wellness products. 
6. EMEDIX  2016 India   www.emedix.in  It gives better delivery and excellent services 
to the consumers nationwide 
 
6. E-PHARMACY IMPACT ON ECONOMY GROWTH 
Telemedicine have adapted at the time of lockdown by 
governments, hospitals, e-pharmacies and even corporate for 
their employee wellness 23.  
In 2016 E-Pharmacy market was valued USD 33.03 billion is 
projected to grow at a CAGR of 14.8% during the forecast 
period. Use of internet increased day by day which impact on 
the improved healthcare infrastructure, rapid aging of the 
population and e-commerce growth Furthermore, rising 
adoption of ecommerce and digital technologies in 
healthcare sector is expected to propel growth 24. Online 
pharmacy market in India is in an emerging stage compared 
to the other developed economies and the major developing 
economies. In recent years around 250 online pharmacies 
have sprung up in the country. According to Frost & Sullivan, 
the e-pharmacy market in India is estimated to grow at an 
exponential CAGR of 63% and reach $3.6 billion by 2022 
from the current $512 million market (2018). E-pharmacy 
presently accounts for ~1.5-2% of the total pharma sale 
according to NetMeds, and 10% growth estimated for 
coming 2023 25.  
7.  PHARMACEUTICAL SECTOR IN PANDEMIC 
SITUATION  
Every industry is impacted by Covid-19 causing head log into 
the global economy. Pharma industry is also impact by this 
pandemic situation. The pharmaceutical industry in India is 
the third largest drug producer by volume and 60% of 
vaccines are manufactures in country.   
 The cost of the raw material and drug hiked up almost 
in all over the world due to lockdown for example in 
India price of paracetamol  has gone up to 400-450 Rs 
per kg from 250- 300 Rs per kg and also price of 
vitamins and penicillin have increased by 40- 50 % . 
 India is major source of APIs for generic drug 
manufacturing across globe and also supplies 
approximately 30% of the generic APIs used in the US. 
Somehow formulations of drug in India depend upon 
the China APIs and procure around 70% from China. 
According to a recent survey, emergency care, 
anesthesia care, and pain management drugs are the 
drugs which mostly get affected due to shortage in the 
pandemic situation. 
 The impact of Covid-19 on demand for drugs 
availability and the lockdown in various countries so 
FDA may be force to allow some relaxation policy in 
review process and regulation on devices. 
 Approximately 10 to 15% earning of pharma firms cur 
down due to Covid-19 because of disruption of supply 
chain.  
 Digital health platform is booming at the pandemic 
time. 
 The Indian government takes a beneficial step by 
proposing an incentive package of 13.76 billion Indian 
Rupees for the promotion of domestic manufacturing of 
critical key starting materials, drug intermediates, APIs 
and medical devices. 
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 Countries should establish or strengthen pharmacy 
support services in combating the coronavirus 
pandemic 26. 
 (E-pharmacies are expected to grow 7 times to $3.7 billion 
by 2022 in this pandemic situation which can be a boon for 
the pharmaceutical industry said by Rajnath Singh) in 
Pharma times.  
8. E- PHARMACY IMPACT ON SOCIETY  
Some highlighted point when it is beneficial to the society at 
the pandemic condition  
E-pharmacy will be work with other healthcare 
organizations, professionals, and government agencies to 
address in that panic situation for customers. As already 
discussed E-Pharmacies give add value in the health care 
system because it is more convenient and easily accessible in 
the pandemic condition when consumers are not go outside 
due to lockdown and safety concern matter. It is also 
approachable services due to transparency of price, medicine 
reminder with health care service provider scheme. E-
pharmacies slog as “Evolving as a One Stop Solution for All 
Healthcare Needs”.  
Medlife spokesperson said, “Our vision has always been to 
provide as many people with easy access to our end-to-end 
healthcare offerings from the comfort of their homes. The 
ongoing Covid-19 pandemic has not altered this vision in 
anyway, but has pushed us to augment our services, being 
the largest e-health enterprise in the country. While online 
medicine delivery service is our main pillar, other services 
like consultation services and home diagnostics have also 
seen a spike. With more and more people opting to stay 
indoors, we are ensuring that they do not forego their 
necessary diagnostics tests by sending our phlebotomists to 
their doorsteps.” 
Some factors why e-pharmacy gains popularity are India 
ranks high in premature deaths caused by non 
communicable diseases according to the WHO. Day by day 
these chronic diseases in India are growing very fast. These 
non communicable diseases affect by rapid urbanization, 
mechanization, increased motorization and sedentary 
lifestyle, especially in adults. Access of medicine in the 
remote villages is inadequate. The Internet gives knowledge 
of all the medicines with the help of qualified specialists and 
doctors, so it difficult for physically locate consumer. 
Through telemedicine, a village dweller in India can also 
interact with top specialists anywhere in large cities, or 
perhaps even globally.  
The e-pharmacy websites provide health blogs which 
provide information about the drugs purchased like 
indications, adverse effects and dosage requirement. They 
also provide information and awareness about various 
medical conditions to increase patient education and 
awareness. 
E-Pharmacy model also give knowledge about the diseases, 
preventive measure, side effect, herbal treatments and 
adverse effect and interaction of drug issue related to drug 
and their treatments just like in the covid-19 information 
spread globally with the help of internet 27.     
9. GOVERNMENT INITIATIVE:  
Government of India headed Digital India program 
perceiving a transformation of country into digitally 
empowered society with economy knowledge. This program 
insures that services of Government's are available to 
citizens by electronically. 
 Government initiatives in E-health care system. The 
Ministry of Health & Family Welfare has undertaken various 
initiatives using Information & Communication Technologies 
(ICT) for improving the efficiency and effectiveness of the 
public healthcare system. The parts of the e-health care are 
National health portal, e-Hospital @nic, online 
registration system and SUGAM 28. These government 
initiatives will provide online platform for the patient’s 
services and also make people familiar about online health 
system. Another scheme is Ayushman Bharat Health 
Insurance Scheme which provides service to create a 
healthy, capable, and content. Some E-pharmacy startups 
have tie-ups with health insurers and customers get 
medicines at cheaper prices which affectively increase the 
ratio of buying medicines through e-Pharmacy portals. For 
giving push to the make in India initiative DCGI announced a 
plan of single-window facility start soon for aiming ease of 
doing business. Jan Aushadhi Program: This model creates 
awareness and easily access low price medicine to the 
population without any compromise in quality. Jan Aushadhi 
stores provide high quality generic drugs at low prices, 
create awareness through education and publicity that high 
prices of drug does not imply high efficacy and potency, 
Encourage doctors, more specifically in Government 
hospitals to prescribe generic medicines 29. 
9. CONCLUSION AND FUTURE PROSPECTIVE  
The objective of the E-pharmacy is development of nation 
with clear and tangible benefits to the consumers as well as 
the industry. E-Pharmacy is an attractive model which 
innovate online healthcare system and also create a huge 
demand in future. The market size of the e-pharmacy in the 
next coming 4 year is about 360 million US$ according to the 
New EY report. It is more efficient and responsible than local 
pharmacy in remote areas, which provides easy and 
affordable medicines to the consumer at their doorstep in a 
one click and also gives knowledge about the medicinal 
remedies awareness to the buyer.  In a report 76% 
respondents said that e-Pharmacy is more convenient as 
compared to the existing mode of purchase. 35% of 
pharmaceutical market in India relates with the chronic 
diseases and 65% to acute medicine type so as expected e-
pharmacy can target 85% of chronic market and 40% of the 
acute market in booming the e-commerce business and if it is 
not properly regulated so it can be dangerous in future. As in 
the Pandemic situation everything is shut down while most 
of the brick-and-mortar pharmacies continue to function in 
lockdown because many consumers have switched to buying 
medicines online for fear of getting infected by the novel 
covid-19 and ongoing lockdown has both opportunities and 
challenges for the e-pharmacy worldwide. As we know that 
online pharmacy has various advantages and scope increase 
in e-commerce so that Indian Government must think about 
the better regulation and can be boon for the society as well 
as pharmaceutical industry in upcoming years.   
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